Home › Funds › Royce & Associates › MXCT
Royce & Associates position in MXCT
MAXCYTE INC · Health Care
Latest position (Q2 2025)657.08K sh
Reported value held$1.43M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.41M | $17.25M | New |
| Q4 2021 | 1.30M | $13.28M | Reduce |
| Q1 2022 | 1.24M | $8.70M | Reduce |
| Q2 2022 | 113.00K | $534.00K | Reduce |
| Q3 2022 | 221.32K | $1.44M | Add |
| Q4 2022 | 270.12K | $1.48K | Add |
| Q1 2023 | 307.93K | $1.52K | Add |
| Q2 2023 | 398.78K | $1.83M | Add |
| Q3 2023 | 422.56K | $1.32M | Add |
| Q4 2023 | 327.34K | $1.54M | Reduce |
| Q1 2024 | 81.43K | $341.18K | Reduce |
| Q2 2024 | 202.65K | $794.40K | Add |
| Q3 2024 | 323.92K | $1.26M | Add |
| Q4 2024 | 799.87K | $3.33M | Add |
| Q1 2025 | 1.04M | $2.84M | Add |
| Q2 2025 | 657.08K | $1.43M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MXCT
- Vanguard Group 5.54M sh · $8.59M · Q4 2025
- Morgan Stanley 3.69M sh · $4.54M · Q2 2026
- BlackRock Inc 3.06M sh · $3.76M · Q2 2026
- Renaissance Technologies 1.91M sh · $2.35M · Q2 2026
- AQR Capital Management 1.88M sh · $2.32M · Q2 2026
- Two Sigma Investments 1.46M sh · $1.80M · Q2 2026
- Geode Capital Management 1.33M sh · $1.63M · Q2 2026
- Goldman Sachs Group 1.24M sh · $1.53M · Q2 2026
- Millennium Management 1.20M sh · $1.48M · Q2 2026
- Marshall Wace 1.01M sh · $1.25M · Q2 2026
- Citadel Advisors 955.72K sh · $1.18M · Q2 2026
- Point72 Asset Management 299.85K sh · $368.82K · Q2 2026